The Australia story: Current status and future challenges for the clinical applications of psychedelics
British Journal of Pharmacology December 19, 2024 David Nutt, Peter Hunt, Anne Katrin Schlag et al. 21 citations
Abstract The past decade has seen a huge increase in clinical research with psychedelic drugs and 3,4‐methylenedioxymethamphetamine (MDMA), which have revealed great potential for treating mental health conditions. Given this progress in research, as well as the current unmet clinical need of millions of patients, in 2023, the Australian Therapeutic Goods Administration (TGA) approved the use...